RAB8A Antikörper (Middle Region)
Kurzübersicht für RAB8A Antikörper (Middle Region) (ABIN926981)
Target
Alle RAB8A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Hund, Maus, Ratte (Rattus), Frosch, Huhn, Rind (Kuh), Zebrafisch (Brachydanio rerio)
-
Aufreinigung
- Purified
-
Immunogen
- RAB8 A antibody was raised in rabbit using the middle region of RAB8 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
RAB8A Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this RAB8A antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RAB8A (RAB8A, Member RAS Oncogene Family (RAB8A))
-
Andere Bezeichnung
- RAB8A
-
Hintergrund
- RAB8A is a member of the RAS superfamily which are small GTP/GDP-binding proteins with an average size of 200 amino acids. The RAS-related proteins of the RAB/YPT family may play a role in the transport of proteins from the endoplasmic reticulum to the Golgi and the plasma membrane. The putative effector-binding site of this protein is similar to that of the RAB/YPT proteins. However, this protein contains a C-terminal CAAX motif that is characteristic of many RAS superfamily members but which is not found in YPT1 and the majority of RAB proteins. Although this gene was isolated as a transforming gene from a melanoma cell line, no linkage between MEL and malignant melanoma has been demonstrable. Synonyms: Polyclonal RAB8A antibody, Anti-RAB8A antibody, RAB8A, member RAS oncogene family antibody, MEL antibody, RAB8 antibody.
-
Pathways
- M Phase, Regulation of long-term Neuronal Synaptic Plasticity, SARS-CoV-2 Protein Interaktom
Target
-